About Kevin Xiong

Kevin Xiong is a Vice President and Wealth Advisor at J.P. Morgan Wealth Management.

As the team's head of client strategy, Kevin provides holistic financial guidance to founders, families, and corporate executives in shaping their investment and wealth planning strategies before and after liquidity events.

Kevin's approach draws upon years of advisory and strategic leadership in the innovation economy. As a consultant in McKinsey & Company's San Francisco office, Kevin advised executive teams of Fortune 100 healthcare, technology, and consumer companies on growth strategy, digital transformation, and operational excellence. His digital health expertise led him to Microsoft-funded health data startup Truveta, where he helped the company secure its Series A funding round and grow to over 100 employees. Subsequently, Kevin was recruited by Cedar, a healthcare fintech unicorn backed by Andreessen Horowitz, Founders Fund, Tiger Global, and Thrive Capital to serve as Chief of Staff, then as Director of Product Strategy & Operations. Motivated by a desire to work directly with clients to make an impact in their lives, Kevin rejoined J.P. Morgan, where he began his career over a decade ago as a Summer Analyst.

Kevin graduated magna cum laude from Harvard College with an A.B. in Economics and secondary (minor) in Applied Mathematics. He also holds a Master of Philosophy in Asian & Middle Eastern Studies from the University of Cambridge, graduating with first-class honors as a John Eliot Harvard-Cambridge Scholar.

In his spare time, Kevin enjoys painting, singing, sailing, and cooking with his fiancé. Kevin is fluent in Mandarin and volunteers with several non-profits, including as a trustee of the Charity of Edward Hopkins, the U.S.' oldest charitable trust.

Insights

Cybersecurity

5 ways to boost your kids’ fraud prevention savvy

October 23, 2024With the increasing complexity of fraud schemes, it’s important your kids understand how to keep their accounts and personal information safe.Read Now
Investing

The agony & the ecstasy

October 18, 2024The risks and rewards of a concentrated stock position.Read Now
Markets

T-minus 75 'til 2025: What every investor should know

October 18, 2024Does your portfolio need a tune-up? Here are a few sound principles to keep in mind.Read Now
Personalized guidance begins with a conversation.
Access the firm-wide capabilities of a global financial leader at your side. Take the next step to unlock new opportunities that align with your financial goals.